Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

From the conference call (bold print my doing):

>Our competitors' recent promotional activities with HCPs have allowed HCPs to be more comfortable prescribing branded prescription treatments. In a similar fashion, disease education and DTC advertising by our competitors has helped enable patients to go into the doctor or health care providers' office. This has paved the way for TRULANCE, and we're going to do our best to take advantage of this strong market opportunity and focus on the Rx-ready patient. We are currently doing that with a compelling direct-to-patient, or DTP, approach that focuses on these Rx-ready patients. I think it's worth noting that we are also evaluating large-scale DTC advertising opportunities for the near future, especially because we feel that TRULANCE product profile links strongly to a DTC opportunity. But before a DTC campaign is launched, it is imperative that you meet certain brand awareness and market access objectives first. We do not want to do DTC too soon where it could benefit the competition. So as we prepare for DTC advertising, we will continue to push our DTC approach, both from a branded and nonbranded perspective.<

https://finance.yahoo.com/news/edited-transcript-sgyp-earnings-conference-120058174.html?.tsrc=applewf

GENIUS:)